Branching into RNAi

Dr. David Sabatino completed his B.Sc. (2002) and Ph.D. (2007) at McGill University in nucleic acid biochemistry and his post-doctoral training at l’Université de Montréal in 2010 developing synthetic peptide mimics. Dr. Sabatino was then appointed faculty in the Department of Chemistry and Biochemistry at Seton Hall University and held a joint appointment in the Department of Medical Sciences at the Hackensack-Meridian School of Medicine where he engaged multiple biomedical research collaborations. In January 2022, Dr. Sabatino joined the faculty at Carleton University where he is currently Associate Professor in the Department of Chemistry and Institute of Biochemistry. Dr. Sabatino’s research aims to explore the influence of structural modifications on the anti-cancer activity of biological molecules for drug discovery applications. Dr. Sabatino is co-author of more than 40 peer-reviewed scientific publications, conference proceedings, patents and a book chapter. Dr. Sabatino has also co-authored more than 70 conference presentations in regional, national and international meetings. Dr. Sabatino has also received funding support from the federal governments (NIH, NCI, NSERC and CFI) of USA and Canada for research related to the development of anti-cancer treatment strategies. His research accomplishments have been recognized and awarded, with being most recently nominated Researcher of the Year in 2019.